Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Medical paternalism and expensive unsubsidised drugs.

Literature DB >> 16269497

Medical paternalism and expensive unsubsidised drugs.

Michael Jefford¹, Julian Savulescu, Jacqui Thomson, Penelope Schofield, Linda Mileshkin, Emilia Agalianos, John Zalcberg.

Abstract

Keywords: Health Care and Public Health

Mesh：

Substances：

Year: 2005 PMID： 16269497 PMCID： PMC1283198 DOI： 10.1136/bmj.331.7524.1075

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

13 in total

1. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

Authors: H Joensuu; P J Roberts; M Sarlomo-Rikala; L C Andersson; P Tervahartiala; D Tuveson; S Silberman; R Capdeville; S Dimitrijevic; B Druker; G D Demetri
Journal: N Engl J Med Date: 2001-04-05 Impact factor: 91.245

Review 2. Unconventional therapies for cancer and cancer-related symptoms.

Authors: A J Vickers; B R Cassileth
Journal: Lancet Oncol Date: 2001-04 Impact factor: 41.316

Review 3. The impact of pharmacotherapy policy: a case study.

Authors: R Tamblyn
Journal: Can J Clin Pharmacol Date: 2001

4. The price tag on progress--chemotherapy for colorectal cancer.

Authors: Deborah Schrag
Journal: N Engl J Med Date: 2004-07-22 Impact factor: 91.245

5. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Authors: D J Slamon; B Leyland-Jones; S Shak; H Fuchs; V Paton; A Bajamonde; T Fleming; W Eiermann; J Wolter; M Pegram; J Baselga; L Norton
Journal: N Engl J Med Date: 2001-03-15 Impact factor: 91.245

6. Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease.

Authors: A D Federman; A S Adams; D Ross-Degnan; S B Soumerai; J Z Ayanian
Journal: JAMA Date: 2001-10-10 Impact factor: 56.272

7. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.

Authors: H von der Maase; S W Hansen; J T Roberts; L Dogliotti; T Oliver; M J Moore; I Bodrogi; P Albers; A Knuth; C M Lippert; P Kerbrat; P Sanchez Rovira; P Wersall; S P Cleall; D F Roychowdhury; I Tomlin; C M Visseren-Grul; P F Conte
Journal: J Clin Oncol Date: 2000-09 Impact factor: 44.544

8. Use of complementary and alternative medicine in patients with cancer: a UK survey.

Authors: J A Scott; N Kearney; S Hummerston; A Molassiotis
Journal: Eur J Oncol Nurs Date: 2005-06 Impact factor: 2.398

9. How the internet affects patients' experience of cancer: a qualitative study.

Authors: Sue Ziebland; Alison Chapple; Carol Dumelow; Julie Evans; Suman Prinjha; Linda Rozmovits
Journal: BMJ Date: 2004-03-06

10. Benefits and risks of increasing restrictions on access to costly drugs in Medicaid.

Authors: Stephen B Soumerai
Journal: Health Aff (Millwood) Date: 2004 Jan-Feb Impact factor: 6.301

7 in total

1. A comprehensive service.

Authors: Tony Delamothe
Journal: BMJ Date: 2008-06-14

2. Demands for 'off-licence' access to trastuzumab (Herceptin): content analysis of UK newspaper articles.

Authors: Daniel Hind; Allan J Wailoo; Paul Sutcliffe
Journal: Health Expect Date: 2011-03 Impact factor: 3.377

3. Less than ideal: how oncologists practice with limited drug access.

Authors: Kelvin K Chan; Bertha Wong; Lillian L Siu; Sharon E Straus; José Chang; Scott R Berry
Journal: J Oncol Pract Date: 2012-01-10 Impact factor: 3.840

4. Are cancer drugs less likely to be recommended for listing by the Pharmaceutical Benefits Advisory Committee in Australia?

Authors: Lesley Chim; Patrick J Kelly; Glenn Salkeld; Martin R Stockler
Journal: Pharmacoeconomics Date: 2010 Impact factor: 4.981